Talkspace Debt to Equity Ratio 2020-2025 | TALK

Current and historical debt to equity ratio values for Talkspace (TALK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Talkspace debt/equity for the three months ending March 31, 2025 was 0.00.
Talkspace Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $0.02B $0.11B 0.18
2024-12-31 $0.02B $0.12B 0.18
2024-09-30 $0.02B $0.12B 0.18
2024-06-30 $0.02B $0.11B 0.17
2024-03-31 $0.02B $0.12B 0.16
2023-12-31 $0.02B $0.12B 0.20
2023-09-30 $0.02B $0.12B 0.19
2023-06-30 $0.02B $0.12B 0.17
2023-03-31 $0.02B $0.12B 0.19
2022-12-31 $0.03B $0.13B 0.23
2022-09-30 $0.03B $0.14B 0.23
2022-06-30 $0.03B $0.16B 0.19
2022-03-31 $0.03B $0.18B 0.17
2021-12-31 $0.03B $0.19B 0.16
2021-09-30 $0.04B $0.21B 0.20
2021-06-30 $0.07B $0.20B 0.34
2021-03-31 $0.41B $0.01B 81.96
2020-12-31 $0.13B $-0.10B -1.33
2020-09-30 $0.41B $0.01B 82.11
2020-06-30 $0.41B $0.01B 82.14
2020-03-31 $0.00B $0.00B 0.00
2019-12-31 $0.00B $0.00B 0.00
2019-09-30 $0.00B $0.00B 0.00
2019-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.477B $0.188B
Talkspace Inc. is a virtual behavioral healthcare company. It delivered services through an easy-to-use and fully encrypted web and mobile platform, consistent with HIPAA and other state regulatory requirements. The company offers treatment options for almost every need. Talkspace Inc., formerly known as Hudson Executive Investment Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.064B 58.60
Hims & Hers Health (HIMS) United States $13.260B 137.77
Tempus AI (TEM) United States $12.137B 0.00
IRhythm Technologies (IRTC) United States $4.628B 0.00
Inspire Medical Systems (INSP) United States $3.753B 58.64
Hinge Health (HNGE) United States $2.965B 0.00
Privia Health (PRVA) United States $2.730B 186.58
Enovis (ENOV) United States $1.764B 9.83
Schrodinger (SDGR) United States $1.532B 0.00
Phreesia (PHR) United States $1.519B 0.00
Clover Health Investments (CLOV) United States $1.440B 0.00
Azenta (AZTA) United States $1.342B 62.36
Omnicell (OMCL) United States $1.335B 23.55
10x Genomics (TXG) United States $1.300B 0.00
Claritev (CTEV) United States $0.661B 0.00
Fulgent Genetics (FLGT) United States $0.617B 0.00
Butterfly Network (BFLY) United States $0.544B 0.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.387B 0.00
TruBridge (TBRG) United States $0.348B 771.33
Outset Medical (OM) United States $0.336B 0.00
Health Catalyst (HCAT) United States $0.265B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.195B 0.00
KORU Medical Systems (KRMD) United States $0.150B 0.00
EUDA Health Holdings (EUDA) Singapore $0.134B 0.00
Pulmonx (LUNG) United States $0.109B 0.00
American Well (AMWL) United States $0.104B 0.00
CareCloud (CCLD) United States $0.099B 3.79
MDxHealth SA (MDXH) Belgium $0.093B 0.00
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.043B 0.00
Zepp Health (ZEPP) Netherlands $0.033B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00